Evotec News
Most Popular Evotec Story
Evotec adds drugs in Renovis buyout
Germany's Evotec is boosting its pipeline to five compounds with the acquisition of Renovis for $152 million in an all-stock transaction. An insomnia drug is slated to begin a human clinical trial by Read more...
Latest Headlines
- September 6, 2011
- June 24, 2011
- March 10, 2011
- December 16, 2010
- May 10, 2010
- January 19, 2010
- May 6, 2009
- March 27, 2009
- March 9, 2009
- December 3, 2008
- October 30, 2008
- October 16, 2007
- September 19, 2007
- December 20, 2006
- December 13, 2006
- November 30, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
